Streetbeat News

Regulatory

CZR

The DOJ supports a lawsuit accusing Las Vegas hotels, including Caesars Entertainment Inc., of using algorithms to fix prices. The case, dismissed by a district court, is now on appeal and could impact similar future cases.

Portfolio Pulse from Benzinga Newsdesk

October 25, 2024 | 4:13 pm

CG

TKAMY

Carlyle Group has withdrawn its bid for Thyssenkrupp's defense unit due to indecision from the German government. This decision may impact Carlyle's investment strategy and Thyssenkrupp's future plans for the unit.

Portfolio Pulse from Benzinga Newsdesk

October 25, 2024 | 4:08 pm

ANSS

SNPS

The UK's Competition and Markets Authority (CMA) has initiated an antitrust review of Synopsys Inc's $34 billion acquisition of Ansys Inc due to potential competition concerns. The review is part of the CMA's increased scrutiny of tech sector mergers, particularly those involving AI, cloud services, and chip design. The decision on whether to proceed to an in-depth review will be made by December 20.

Portfolio Pulse from Anusuya Lahiri

October 25, 2024 | 3:45 pm

BTCUSD

Polymarket traders speculate on topics Donald Trump might discuss during his appearance on 'The Joe Rogan Experience,' with high chances of mentioning McDonald's, trans issues, and possibly crypto. This reflects the growing intersection of politics and cryptocurrency as the 2024 elections approach.

Portfolio Pulse from Murtuza Merchant

October 25, 2024 | 3:41 pm

ITRM

Iterum Therapeutics' shares rise following FDA approval of ORLYNVAH for treating uncomplicated urinary tract infections.

Portfolio Pulse from Benzinga Newsdesk

October 25, 2024 | 3:17 pm

MCD

McDonald's shares are declining following an FDA report of 75 E. coli infections across 13 states linked to the company.

Portfolio Pulse from Benzinga Newsdesk

October 25, 2024 | 3:13 pm

MCD

The FDA reports an E. Coli O157:H7 outbreak linked to McDonald's Quarter Pounders, affecting 75 people across 13 states as of October 24.

Portfolio Pulse from Benzinga Newsdesk

October 25, 2024 | 3:07 pm

UPXI

Upexi, Inc. (NASDAQ:UPXI) shares surged over 300% on Friday following the company's announcement of a review into potential stock manipulation related to a recent 12-for-1 reverse stock split. The trading volume was significantly higher than average, with a notable increase in the number of shareholders.

Portfolio Pulse from Dylan Berman

October 25, 2024 | 3:00 pm

ITRM

The FDA has approved Iterum Therapeutics' New Drug Application (NDA) for ORLYNVAH, a treatment for uncomplicated urinary tract infections. This approval is a significant milestone for Iterum Therapeutics.

Portfolio Pulse from Benzinga Newsdesk

October 25, 2024 | 2:52 pm

META

TRI

Meta has entered a multi-year agreement with Reuters to use its news content for real-time answers in its AI chatbot. This marks Meta's first news deal in the AI era, allowing users to access Reuters' news through Meta's platforms. The partnership highlights Meta's shift in news content strategy amid regulatory scrutiny.

Portfolio Pulse from Benzinga Newsdesk

October 25, 2024 | 2:47 pm